Sarepta Therapeutics, Inc. (SRPT)
NASDAQ: SRPT · Real-Time Price · USD
17.71
+1.02 (6.11%)
At close: Mar 23, 2026, 4:00 PM EDT
17.81
+0.10 (0.56%)
After-hours: Mar 23, 2026, 7:45 PM EDT
Sarepta Therapeutics Analyst Ratings
Total Analysts
28
Consensus Rating
Hold
Price Target
$25.24
Upside
+42.52%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Reiterates $37 | Buy | Reiterates | $37 | +108.92% | Mar 19, 2026 |
| Mizuho | Mizuho | Buy Maintains $26 → $31 | Buy | Maintains | $26 → $31 | +75.04% | Mar 13, 2026 |
| Citigroup | Citigroup | Strong Sell Maintains $8 → $9 | Strong Sell | Maintains | $8 → $9 | -49.18% | Mar 10, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Sell Reiterates $5 | Strong Sell | Reiterates | $5 | -71.77% | Mar 2, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $45 → $38 | Buy | Maintains | $45 → $38 | +114.57% | Feb 27, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Sell Reiterates $5 | Strong Sell | Reiterates | $5 | -71.77% | Jan 27, 2026 |
| Wedbush | Wedbush | Buy Maintains $32 → $34 | Buy | Maintains | $32 → $34 | +91.98% | Jan 23, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Sell Reiterates $5 | Strong Sell | Reiterates | $5 | -71.77% | Jan 14, 2026 |
| Wedbush | Wedbush | Buy Initiates $32 | Buy | Initiates | $32 | +80.69% | Dec 9, 2025 |
| Barclays | Barclays | Hold Maintains $22 → $20 | Hold | Maintains | $22 → $20 | +12.93% | Nov 5, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $50 → $45 | Buy | Maintains | $50 → $45 | +154.09% | Nov 5, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $22 → $19 | Strong Buy | Maintains | $22 → $19 | +7.28% | Nov 5, 2025 |
| Mizuho | Mizuho | Hold → Buy Upgrades $19 → $26 | Hold → Buy | Upgrades | $19 → $26 | +46.81% | Nov 5, 2025 |
| Baird | Baird | Hold Maintains $21 → $15 | Hold | Maintains | $21 → $15 | -15.30% | Nov 4, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $15 → $16 | Hold | Maintains | $15 → $16 | -9.66% | Oct 30, 2025 |
| BMO Capital | BMO Capital | Hold → Buy Upgrades $50 | Hold → Buy | Upgrades | $50 | +182.33% | Sep 22, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.